semaglutide drinking alcohol and - Do They Mix? GLP-1 medications: The next big

The GLP-1 receptor activation suppresses appetite, slows gastric emptying, and enhances insulin secretion

External resources Phase 2 Retatrutide Trial - New England Journal of Medicine , the primary clinical source for retatrutide efficacy and safety data including sex-stratified outcomes

Liraglutide ameliorates beta-cell function, alleviates oxidative stress and inhibits low grade inflammation in young patients with new-onset type 2 diabetes

Sometimes, changes may be needed based on what you need or the type of device you use

Rybelsus Delays Gastric Emptying The Rybelsus Prescribing Information warns: RYBELSUS causes a delay of gastric emptying, and thereby has the potential to impact the absorption of other oral medications. However, there is no specific warning for stomach paralysis or gastroparesis on the label

Why Blood Sugar May Not Be Very High In classic DKA: Insulin deficiency severe hyperglycemia In euglycemic DKA: Some insulin is still being administered Blood glucose may appear only mildly elevated But insulin is insufficient to prevent ketogenesis This can delay recognition because: Patients and clinicians may not suspect DKA with glucose under 250 mg/dL Symptoms may initially resemble dehydration or GI illness Additional Contributing Factors GLP-1 use in Type 1 diabetes may also increase DKA risk due to: Vomiting dehydration stress hormones ketone rise Intentional insulin reduction due to fear of hypoglycemia Reduced basal insulin during weight loss Increased glycemic variability from delayed gastric emptying Hypoglycemia and the Insulin Reduction Trap Another issue is the cycle that can develop: Appetite decreases Insulin dose is reduced Hypoglycemia occurs intermittently Insulin is reduced further Ketone production increases Over time, this can push the patient into metabolic instability